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MaBACKGROUND Arterial 18fluorodeoxyglucose (FDG) positron emission tomography (PET) is considered a measure of
atherosclerotic plaque macrophages and is used for quantification of disease activity in clinical trials, but the distribution
profile of FDG across macrophages and other arterial cells has not been fully clarified.
OBJECTIVES The purpose of this study was to analyze FDG uptake in different arterial tissues and their contribution to
PET signal in normal and atherosclerotic arteries.
METHODS Wild-type and D374Y-PCSK9 transgenic Yucatan minipigs were fed a high-fat, high-cholesterol diet to induce
atherosclerosis and subjected to a clinical FDG-PET and computed tomography scan protocol. Volumes of arterial media,
intima/lesion, macrophage-rich, and hypoxic tissues were measured in serial histological sections. Distributions of FDG in
macrophages and other arterial tissues were quantified using modeling of the in vivo PET signal. In separate transgenic
minipigs, the intra-arterial localization of FDG was determined directly by autoradiography.
RESULTS Arterial FDG-PET signal appearance and intensity were similar to human imaging. The modeling approach
showed high accuracy in describing the FDG-PET signal and revealed comparable FDG accumulation in macrophages and
other arterial tissues, including medial smooth muscle cells. These findings were verified directly by autoradiography of
normal and atherosclerotic arteries.
CONCLUSIONS FDG is taken up comparably in macrophage-rich and -poor arterial tissues in minipigs. This
offers a mechanistic explanation to a growing number of observations in clinical imaging studies that have been
difficult to reconcile with macrophage-selective FDG uptake. (J Am Coll Cardiol 2019;74:1220–32) © 2019 The Authors.
Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).P ositron emission tomography (PET) imagingwith 18fluorodeoxyglucose (FDG) visualizesglucose uptake in metabolically active tissues.
Signal from arteries has been construed as arising
predominantly from atherosclerotic plaque macro-
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AB BR E V I A T I O N S
AND ACRONYM S
CT = computed tomography
FDG = 18fluorodeoxyglucose
HFHC = high-fat, high-
cholesterol
PET = positron emission
tomography
ROI = region of interest
SMC = smooth muscle cell
SUV = standardized uptake
value
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1221signal (8–10), but there is no quantitative evidence
that macrophages comprise the only or principal site
of FDG accumulation in human arteries. On the con-
trary, studies have revealed nontrivial signal levels
arising from arterial segments with few or no macro-
phages (target to background ratio [TBR] z 1.3 to
1.5) (8–10), and plaque macrophage variation typically
accounts for less than one-half of the variation in
FDG-PET signal (reported range r2 ¼ 0.1 to 0.6)
(Online Table 1). Other abundant arterial cell types,
for example, smooth muscle cells (SMCs), express
glucose transporters and take up FDG in vitro (11),
but the quantitative contribution of nonmacrophages
to the total arterial FDG-PET signal is unknown (1).
This complicates the interpretation of clinical FDG-
PET trials, because it weakens the underlying tenet
that the level and alterations in FDG-PET signal are
directly related to inflammation.SEE PAGE 1233An important obstacle to understanding the sour-
ces of arterial FDG-PET signal is the limited resolution
of PET compared with artery wall dimensions (12),
which prevents demarcation and direct measurement
of signal from arterial subcompartments. Instead, the
combined signal from all sources, including back-
ground, is typically measured within a region of in-
terest (ROI) around the artery, and this composite
measure is correlated empirically with features of
interest, for example, plaque macrophages, without
further attempts to define the physical origin of the
signal.
Detailed investigation of FDG-PET signal sources is
difficult to conduct in humans because of the inac-
cessibility of relevant arteries (e.g., the ascending
aorta) to histological analysis. Small animals are also
unfavorable, because artery wall dimensions are far
below scanner resolution (12). We therefore used
D374Y-PCSK9 transgenic minipigs, which feature ar-
teries and atherosclerotic plaques that are compara-
ble to human arteries and plaques in terms of size and
morphology (13–15).
In the present study, we reproducemany findings of
human FDG-PET in minipigs, supporting the trans-
lational relevance of the animal model. We use a
model-based approach for arterial PET signal to esti-
mate the activity fraction of subresolution tissues
in vivo (16). Using this approach, we provide estimates
of signal arising from separate arterial cellular com-
partments, and we confirm the accuracy of this
approach by tissue autoradiography. Our results show
that arterial FDG-PET signal in atherosclerotic mini-
pigs is not dominated by tracer accumulation inmacrophages, but rather that FDG accumu-
lates equally in other arterial wall tissues,
including SMCs of the arterial media.
METHODS
IN VIVO FDG-PET SCANS. An overview of
the animals used in this study is provided in
Online Figure 1. Wild-type (WT) (6 male) and
transgenic D374Y-PCSK9 (TG) (5 male, 4 fe-
male) minipigs were fed a high-fat, high-
cholesterol (HFHC) diet from 8 to 9 weeks of
age. Other WT minipigs (4 male) were
maintained on a normal diet. At 54 
1.8 weeks of age, minipigs underwent FDG-
PET and computed tomography (CT) imag-
ing at 186  10 min after injection of 493 
28 MBq FDG, followed by euthanasia and histo-
pathological analysis 2 to 4 days later. Pimonidazole
(10 mg/kg) was injected in a subgroup of HFHC-fed
minipigs (7 TG and 4 WT) at 110  16 min before
euthanasia. The atherosclerosis phenotype of the
HFHC-fed TG and WT minipigs in the present study
has been previously described (13). The Danish Ani-
mal Experiments Inspectorate approved all experi-
mental procedures.
AUTORADIOGRAPHY. Four additional TG minipigs (2
male, 2 female)were fedHFHCdiet from8weeks of age
to 80  5 weeks of age and used for autoradiography
experiments (Online Figure 1). Pigs were injected with
482  63 MBq FDG and 93 MBq tritium-deoxyglucose,
and iliac, carotid, and aortic arteries were extracted
after approximately 2 h (Online Figure 2). Three 4-mm
blocks from each vessel with visible lesions were
chosen for autoradiography. Carotidswere lesion-free,
and normal blocks were selected. Blocks were snap-
frozen, cryosectioned (40 mm), and thaw-mounted
onto slides, after which they were dried and apposed
onto phosphor imaging plates along with calibrated
standards for approximately 5 18F half-lives. Addi-
tionally, 5-mm cryosections were apposed onto imag-
ing plates for a period of 19 weeks to record tritium-
deoxyglucose signal. Adjacent sections were pro-
cessed for immunohistochemistry.
TISSUE ANALYSIS. Aortas were Sudan IV-stained and
examined en face to quantify lesion area. Ilio-femoral
arteries of in vivo scanned animals were sliced at 1-cm
intervals and paraffin-embedded. One longitudinal
slice from the major curvature of the ascending aorta
was excised and was paraffin embedded. Sections
were stained with hematoxylin/eosin or orcein, or
with antibodies against muramidase (macrophages)
or pimonidazole (hypoxia).
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were manually delineated excluding any calcium
deposits, measuring total intima and media areas.
Muramidase-positive areas were subtracted to yield
macrophage-free intima and media areas. Necrotic
areas with low cellularity (<10 cell nuclei per
0.01 mm2) were also recorded.
IMAGE ANALYSIS. Fused PET/CT images of the
ascending aorta, superior vena cava, ilio-femoral ar-
teries, and ilio-femoral veins were analyzed, and
careful alignment to tissue specimens was conducted
using anatomical landmarks. An ROI was placed
around arteries, including lumen, and within the
lumen of veins to acquire standardized uptake values
(SUV) calculated according to previous reports (17).
Standardized total ROI activity (AROI) inside an ROI
was calculated through multiplication of the ROI
volume by its average SUV. The background activity,
Abg was calculated by multiplying ROI volume by
average SUV of the reference vein. Analysis of ilio-
femoral arteries were conducted in 12 HFHC-fed
minipigs (4 WT and 8 TG), 10 of which had received
pimonidazole, while the others were excluded due to
spillover signal from the urinary bladder.
STATISTICAL ANALYSIS. Data are represented as
mean  SD. To accommodate any possible grouping
effects in regression analyses, the clustered sand-
wich estimator, with each animal as the grouping
variable, was used to estimate robust standard errors
(18). A p value cut-off of 0.1 was used for initial
selection in stepwise regression with backward
elimination. The variance inflation factor was used
to assess multicollinearity of independent variables
in multivariable regression. Akaike’s information
criterion was used to evaluate the information loss
in regression models. Interobserver agreement for
measurements of total vessel wall area (histology),
AROI and Abg (PET images) in ilio-femoral arteries
were 4.5  8.2%, 4.7  8.2% and 5.6  5.8% (bias 
SD of bias, Bland-Altman method comparison). An-
alyses were conducted using Prism version 6
(Graphpad Software Inc., La Jolla, California) and
Stata version 15 (StataCorp, College Station, Texas).
Significance level was set below 0.05.
Further details on methods are provided in the
Online Appendix.
RESULTS
NO DIFFERENCE IN FDG-PET SIGNAL OF HEALTHY
AND ATHEROSCLEROTIC ASCENDING AORTAS. The
ascending aorta has been used as an important
quantification site for plaque inflammation in human
FDG-PET trials (3–7), but the dominant source ofsignal in this arterial segment, which typically has
less advanced atherosclerosis (19), is uncertain.
HFHC-fed WT and TG minipigs, like humans,
develop mainly early lesion types in the ascending
aorta. Age-matched WT minipigs on normal diet were
free from atherosclerosis. Using an FDG-PET/CT pro-
tocol adapted from clinical studies, we observed
strong FDG accumulation in the ascending aorta of all
animals with TBRs and SUVs comparable in magni-
tude to human observations (Figures 1A to 1F, Online
Figure 3) (17,20). The signal, however, exhibited
limited variation with no correlation to the wide
range of atherosclerosis present across the 3 groups of
minipigs (Figure 1G). Importantly, the clear FDG-PET
signal from healthy aortas indicated that FDG accu-
mulated in the arterial wall irrespective of the pres-
ence of macrophage-containing lesions.
CORRELATIONS BETWEEN PLAQUE MACROPHAGE
CONTENT AND FDG-PET SIGNAL REPLICATED IN
PIGS. For analysis of arteries with progressive
atherosclerotic lesions, we focused on the ilio-
femoral arteries. Serial sections from ilio-femoral ar-
teries were stained for macrophages using immuno-
histochemistry with anti-muramidase antibodies,
previously shown to be a reliable macrophage marker
in pigs (21), and their locations were carefully aligned
to PET/CT slices using anatomic landmarks. Plaque
macrophage content correlated significantly with SUV
and TBR values, but, as in human studies, the varia-
tion in macrophage content could not explain the
majority of the variation in arterial PET signal (r2 #
0.48) (Figure 2). Notably, PET signal was also recor-
ded from vascular segments without macrophages,
showing that also in ilio-femoral arteries, signal of
nonmacrophage origin played an important role.
SIGNAL MODELING FOR ESTIMATING COMPONENTS
OF THE ARTERIAL PET SIGNAL. To identify the un-
recognized sites of FDG accumulation, we derived a
model for the total arterial PET signal, which is based
on the superposition principle and expresses total
activity as the sum of all potential signal components.
Regression analysis over such a signal model can
provide valid estimates of activity fractions origi-
nating from sub-resolution tissue components, as
recently reported (16).
According to the model, signal must arise from
either arterial tissue, residual blood activity, or spill-
over from neighboring regions:
AROI ¼ Ca$Va þ Abg [1]
where AROI is the standardized (to body weight and
tracer dose) total activity in the arterial ROI, Va is the
volume of target arterial tissue, Ca is the recovered






























































(A) Opened Sudan IV–stained aorta from HFHC-fed transgenic minipig showing atherosclerosis (red staining) in the ascending segment (nonshaded area).
(B) Antimuramidase-stained (red) section, obtained at the dashed lines in A and C, showing intimal macrophage infiltration (black arrowheads). (C) Trans-
sectional (top) and longitudinal (bottom) reconstructions of fused PET/CT images of the aorta shown in A. (D) Lesion-free aorta of a wild-type pig on
normal diet. (E) Antimuramidase-stained section corresponding to dashed lines in D and F showing no macrophages. (F) Strong FDG-PET signal from the
nonatherosclerotic aorta. Scale bars are 1 cm (A, C, D, and F) and 0.5 mm (B, E). PET images are decay corrected and color-coded according to displayed
SUV scales (C, F). (G) Boxplot showing range of luminal surface lesion area and scatter plots of conventional vascular FDG-PET measures against lesion
area (n ¼ 19). Similar PET signal measures are recorded from all arteries, and there are no significant differences between healthy and lesioned aorta
groups. The red and pink markers reflect arteries shown in A and D, respectively, displaying similar PET signals. FDG ¼ 18fluorodeoxyglucose;
HFHC ¼ high-fat, high-cholesterol; PET ¼ positron emission tomography.
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(A) Fused PET/CT image of the right ilio-femoral vessels. (B) Opened Sudan IV–stained artery, completely covered by nonraised (dark red) or raised (pink) lesions.
(C and D) Cross sections, stained with orcein (top) and antimuramidase (bottom), showing large lesions with variable macrophage content (black arrowheads). White
arrowheads mark the internal elastic membrane. Dashed lines in A and B represent locations of C and D. Scale bars are 1 cm (A, B) and 1 mm (C, D). (E) Correlations
between plaque macrophage area and FDG-PET signal, displayed with 95% confidence bands. The red and pink markers reflect tissue slices shown in C and D,
respectively, displaying similar PET signals. Serial sections (n ¼ 115) from 12 minipigs were analyzed. I ¼ intima; M ¼ media; other abbreviations as in Figure 1.
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TABLE 1 Model-Based Analysis of FDG-PET Signal
Model Coefficients Unit Robust SE p Value 95% CI R2 AIC
Univariable Models for Individual Arterial Tissue Compartments
AROI ¼ Cx$Vx þ b0
1 Cm4 11.2 g/cm
3 1.69 0.000 7.44 to 14.9 0.51 34.7
b0 0.69 g 0.04 0.000 0.61 to 0.77
2 Cfm 10.7 g/cm
3 3.40 0.010 3.17 to 18.1 0.16 26.3
b0 0.36 g 0.16 0.046 0.01 to 0.71
3 Cfi 5.55 g/cm
3 0.72 0.000 3.96 to 7.15 0.65 74.9
b0 0.64 g 0.03 0.000 0.58 to 0.70
Multivariable Model Including All Arterial Tissues and Background Signal
AROI ¼ Cmf$Vmf þ Cfm$Vfm þ Cfi$Vfi þ Abg þ b0
4 Cm4 2.79 g/cm
3 0.53 0.000 1.63 to 3.95 0.81 139.1
Cfm 3.08 g/cm
3 1.26 0.033 0.31 to 5.85
Cfi 2.58 g/cm
3 0.20 0.000 2.13 to 3.03
b0 0.00 g 0.05 0.962 0.12 to 0.11
The full signal (Model 4) encompassing all possible signal sources explains much more of the FDG-PET/CT signal than any univariable correlation to individual candidate tissues
(Models 1 to 3), as seen by higher determination coefficient (R2) and lower Akaike’s information criterion (AIC). All analyses are based on 115 tissue slices (40 from wild-type and
75 from transgenic pigs fed HFHC-diet). Co-linearity analysis of predictors in model 4 showed variance inflation factors below 2.5.
SE, standard error. AROI ¼ standardized total activity in the ROI. Abg ¼ standardized total activity of background in the ROI; C ¼ recovered standardized activity concentration
of the indicated tissue type; CI ¼ confidence interval; fm ¼ macrophage-free media; fi ¼ macrophage-free intima; m4 ¼ macrophages; b0 ¼ intercept constant; V ¼ tissue
volume.
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standardized total activity of the background inside
the ROI. The background component represents
blood activity and spill-over. It is measured in the
reference vein and is assumed to be a good estimate
for the arterial background. The arterial tissue can be
further split into complementary tissue components,
e.g., macrophage-rich tissue (m4), macrophage-free
media (fm), and macrophage-free intima (fi):
AROI ¼ Cm4$Vm4 þ Cfm$Vfm þ Cfi$Vfi þ Abg [2]
Multivariable regression analysis over this signal
model was carried out for ilio-femoral arteries with
histologically determined subcomponent volumes
and measured values of AROI and Abg (Table 1). This
analysis provided a much higher determination co-
efficient (R2 ¼ 0.81) than any univariable correlation
and a nonsignificant intercept that was close to zero,
implying that no signal sources were omitted.
As seen from the structure of the signal model
equation, and recently validated using simulations
and phantom scans (16), the regression coefficients
are estimates of the activity concentration that is
recovered inside the ROI for macrophage-rich tissue
(Cm4), macrophage-free media (Cfm), and macrophage-
free intima (Cfi). These coefficients were all signifi-
cantly different from zero, indicating that all tissue
types contributed independently to the FDG-PET
signal. Surprisingly, these estimates were also high-
ly similar, indicating comparable FDG accumulation
in different tissue compartments, and opposing the
notion of an exceptionally high FDG accumulation inmacrophages. The strong correlation between total
arterial tissue volume and PET signal is shown
graphically in Figure 3A.
ASCENDING AORTA PET SIGNAL DOMINATED BY
TRACER ACCUMULATION IN THE ARTERIAL MEDIA.
Similar signal modeling was conducted in the
ascending aorta comparing lesioned and nonlesioned
regions (Online Table 2). We found that the amount of
arterial tissue in each region correlated independently
with FDG-PET signal, and that the estimated average
standardized activity concentrations in both regions
were similar. This again indicated that FDG accumu-
lation occurred in bulk arterial tissue, rather than
solely in atherosclerotic lesions with macrophage
infiltration. This was also consistent with the observed
high signal in aortas from healthy minipigs (Figure 1).
Due to the thickness of the tunica media (1.74 
0.24 mm) compared with the intima (0.20  0.15 mm),
the media dominated the total arterial volume, mak-
ing SMCs of the arterial media the source of the ma-
jority of signal even in atherosclerotic aortas. The
correlation between total aortic tissue volume and
PET signal in the aorta is shown in Figure 3B.
NO CONTRIBUTION TO FDG-PET SIGNAL FROM
HYPOCELLULAR REGIONS. FDG accumulates in
cells, and hypocellular plaque regions should there-
fore not contribute noticeably to the PET signal. To
test the accuracy of the signal modeling approach, we
analyzed the signal contribution of hypocellular re-
gions (fewer than 10 cell nuclei per 0.01 mm2) (Online
Figure 4). The analysis showed no significant






































(A) Ilio-femoral arteries from HFHC-fed D374Y-PCSK9 (n ¼ 8) and wild-type minipigs (n ¼ 4). (B) Ascending aortas of HFHC-fed D374Y-PCSK9 (n ¼ 9) and
wild-type minipigs (n ¼ 6), and atherosclerosis-free wildtype minipigs on normal chow (n ¼ 4). Marker diameter is a linear transformation of macrophage
volume (A) and luminal surface lesion area (B). Best fit planes are shown. Abbreviations as in Figure 1.
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whereas the rest of the arterial wall retained a highly
significant correlation (Online Table 3).
SIGNAL MODEL PREDICTIONS CONFIRMED BY
AUTORADIOGRAPHY OF HISTOLOGICAL SECTIONS.
Autoradiography is the gold standard to show PET
tracer distribution in tissues. To confirm the conclu-
sions of the signal model analysis, we conducted
autoradiography of arteries from a new group of
atherosclerotic HFHC-fed TG minipigs (n ¼ 4),
extracted approximately 2 h after coinjection and
in vivo circulation of FDG and tritium-deoxyglucose
(Online Figure 2). This allowed the autoradiography
to reflect tracer accumulation in tissues at the time
point for the FDG-PET scans.
Autoradiographic images showed considerable
FDG accumulation in the media of all arteries,
including lesion-free carotids, with a signal similar in
magnitude to that of the intima/plaque (Figures 4A to
4D). Quantification of intima activity concentrations,
normalized to the activity concentration of adjacent
media, confirmed that intima and media accumulated
FDG comparably (Figure 4E). To compare FDG uptake
in macrophages and macrophage-free intima, we
conducted regression analyses across the autoradio-
graphed sections. We found that the volumes of both
types of tissues correlated independently with the
total intimal activity normalized to macrophage-free
media activity concentration. The estimated regres-
sion coefficients generally indicated similar activity
concentrations in macrophages and macrophage-free
media (Figures 4F to 4H, Online Table 4).The autoradiography results thus confirmed the
prediction of the signal model that the examined
tissues, including normal media, accumulated FDG to
a similar extent, and that macrophages did not
exhibit exceptional tracer concentrations. Tritium-
deoxyglucose autoradiography images agreed with
the FDG images, but had lower signal-to-noise levels
(Online Figure 5).
MACROPHAGE FDG ACCUMULATION AUGMENTED
BY HYPOXIA. Hypoxia has previously been impli-
cated as a modulator of FDG uptake in atherosclerotic
plaques (11). Using pimonidazole as a molecular
probe, we detected hypoxia mainly in macrophage-
rich regions of iliofemoral plaques (Online Figure 6).
Because the effect of hypoxia would be to stimulate
FDG uptake in cells, we performed exploratory
regression analyses using hypoxic volume as inter-
action terms with macrophage-rich and -free intima.
Stepwise regression with backward elimination
removed the hypoxia times macrophage-free intima
term, but the interaction between macrophages and
hypoxia remained in the model with a significant
positive coefficient (Online Table 5), indicating that
hypoxia may augment FDG accumulation
in macrophages.
MACROPHAGE DENSITY NOT INDEPENDENTLY
CORRELATED WITH FDG-PET SIGNAL. Macrophage
density is a variable that has been reported to corre-
late univariably with FDG-PET signal in human
studies (Online Table 1), and we were able to replicate
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(A to D) FDG autoradiography (left) shown with same sections after HE staining (middle), and an adjacent section (right) stained for macrophages (muramidase) from
the carotid artery (A), iliac artery (B), abdominal aorta (C), and ascending aorta (D). Autoradiography images were decay-corrected to injection time and depicted
according to the shown scale (Bq/mm2). Arrowheadsmark examples of arterial media (purple) and intima (green). Scale bars are 1 mm. Note the relatively strong signal
from the nonlesioned carotid section (A). (E) Relative activity concentration in intima compared with media. Bars are mean  SEM. (F to H) Plots of relative intima
activity against volumes of macrophages and macrophage-free intima, showing significant correlations in the iliac arteries (F), abdominal aorta (G), and ascending
aorta (H) of both tissue types. In each territory, sections with visible intima (n ¼ 9) from 4 HFHC-fed transgenic minipigs were included in the analyses (E to H).
rCmf ¼ relative macrophage activity concentration normalized to macrophage-free media activity concentration; other abbreviations as in Figure 1.
J A C C V O L . 7 4 , N O . 9 , 2 0 1 9 Al-Mashhadi et al.
S E P T E M B E R 3 , 2 0 1 9 : 1 2 2 0 – 3 2 18-FDG Accumulates in Multiple Arterial Cell Types
1227













































































Ilio-Fem. Artery Wall Segment Volume (cm3)
Predicted PET signal fractions originating from different arterial wall components and background in iliofemoral sections (n ¼ 115 sections from 12 pigs). The data are
based on the PET signal model 4 regression results presented in Table 1. Fitted semi-log trend lines are presented, p < 0.0001 for all lines (A to D). Abbreviations as in
Figure 1.
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driven by an underlying correlation between macro-
phage density and total arterial volume (r2 ¼ 0.56).
Accordingly, density was rendered insignificant when
total volume was included in multivariable analysis
(Online Table 6).
ARTERIAL FDG-PET SIGNAL NOT DOMINATED BY
MACROPHAGES. The contributions of vessel wall
subcomponents to the overall activity in ilio-femoral
arteries are shown in Figure 5. The contribution of
each arterial component was calculated through
multiplication of its volume by its recovered activity
concentration, obtained from the signal modelinganalysis (Table 1). In atherosclerosis-free arterial
segments, the full signal arises from the media and
background alone. With the occurrence of lesions,
leading to increase in artery wall volume, the artery
signal fraction rises while the background fraction
recedes. For growing lesions, macrophages gain in
relative importance, but the trend lines indicate that
macrophages do not become dominant, even for large
plaques above 15 mm2 in cross-sectional area. Online
Figure 7 shows the predictions based on the signal
model that includes hypoxia in the calculation of the
macrophage signal fraction (Online Table 5), but this
does not affect the overall pattern.
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Accurate quantification of disease activity in athero-
sclerosis is key for identification of individuals at risk
and for measuring effects of therapies. Plaque mac-
rophages are relevant to monitor because of their
pathophysiological importance in the initiation, pro-
gression, and thrombotic complications of athero-
sclerosis, as well as their responsiveness to
antiatherosclerotic therapy (22). Based on the
observed correlations between FDG-PET signal and
plaque macrophage volume or density (1,2), FDG-
PET/CT has been widely used as a noninvasive
method to quantify macrophage-driven inflammation
in human atherosclerosis (3–7). Previous studies,
however, have not been able to quantify all sources of
signal from atherosclerotic arteries, and hence cannot
rule out that FDG uptake in other cell types could be
quantitatively important (1). Indeed, researchers have
found that macrophage content explains some of the
variation in FDG-PET signal from carotid and femoral
arteries with determination coefficients of 0.1 to 0.6
(Online Table 1), but the sources of the residual
variation—often the majority—have been unresolved,
many probably ascribing a large part of this to noise.
The possibility that nonmacrophage tissues may
dominate the level and, thus, alterations in arterial
FDG-PET signal has not been duly considered in the
interpretation of clinical trials.
To address this knowledge gap, we used athero-
sclerotic minipigs and a signal model for arterial PET,
which allowed us to partition the contribution of
different types of arterial tissue and background to
the composite PET signal. The PET signal model
explained the vast majority of signal variation,
demonstrating the low level of noise and quantitative
power of arterial PET for measuring processes in the
arterial wall when conducted in a well-controlled
setting and using the quantitative measures of the
present study. Importantly, the model-based pre-
dictions could be fully confirmed by autoradiography,
and the combined body of data showed that FDG
accumulation was not predominant in macrophages,
but occurred at similar magnitude in other arterial
tissues, including healthy arterial media (Central
Illustration). One important consequence is that in
the ascending aorta, where the bulk of tissue is me-
dia, only a minority of the FDG-PET signal is derived
from cells in atherosclerotic lesions.
CELL TYPES. The arterial tissue partitioning in our
analysis was designed to focus on macrophages, but
also allows conclusions on SMCs, because the arterial
media is a practically pure SMC population. These 2cell types constitute—by far—the most abundant cell
types in the atherosclerotic arterial wall. It would in
principle be possible to estimate FDG uptake in other
cell types, for example, lymphocytes, by alternative
tissue subdivisions, but their lower numbers in
typical plaques (23) makes a quantitative important
contribution to FDG PET signal less likely.
TRANSLATION FROM MINIPIG EXPERIMENTS TO
HUMAN FDG-PET IMAGING. Extrapolating from
experimental models to humans is complex, but 2
lines of arguments support the relevance of our
findings for human imaging.
First, the conditions and appearance of FDG-PET/CT
imaging in minipigs are close to clinical imaging.
D374Y-PCSK9 minipigs develop atherosclerosis with
macrophage infiltration, foam cell formation, necrosis,
calcification, andfibrous tissue formation (13–15). Also,
hypoxia, as shown in the present study (Online
Figure 6), has an intraplaque distribution similar to
that of human plaques (24). In both pigs and humans,
advanced lesions form consistently in the ilio-femoral
arteries (13), while the ascending aorta is typically
limited to less advanced lesion types (19). Of particular
importance for imaging, minipigs resemble humans in
terms of body size and vessel dimensions, and thus
present similar challenges to imaging with suboptimal
resolution (12). We used a scan protocol with late
acquisition similar to those used in human studies, and
we obtained comparable signal levels with conven-
tional PET quantification measures (17,20). Further-
more, we found univariable correlations between FDG
signal and plaquemacrophage content consistent with
the range of determination coefficients reported in
human studies (Online Table 1) (8–10).
Second, the conclusions from our experiments, in
particular the significant uptake of FDG in medial
SMCs, are consistent with several clinical observa-
tions that have hitherto lacked mechanistic explana-
tions. This includes: why PET signal in humans is
observed from all vascular sections, including those
without macrophages (8–10); why FDG uptake corre-
lates with carotid artery stenosis, irrespective of the
degree of inflammation (25); why humans of all ages
(5 to 80 years) show FDG accumulation in the aorta
(26); and why human aortic signal is relatively high
(27), even though atherosclerosis is often limited in
this region compared with other vessels (19). It may
also help explain why aortic FDG-PET signal is rather
stable over time compared with other atherosclerotic
arteries (27) and why several clinical trials failed to
detect signal changes in the ascending aorta, even
when changes in other vessels were present (5,6).
Moreover, our findings provide in vivo confirmation
CENTRAL ILLUSTRATION Cellular Sources of 18Fluorodeoxyglucose–Positron Emission
Tomography Signal
Al-Mashhadi, R.H. et al. J Am Coll Cardiol. 2019;74(9):1220–32.
Top panel: Schematic representation of an arterial cross-section showing an atherosclerotic plaque with macrophage infiltration. Different
arterial tissues accumulate similar 18fluorodeoxyglucose (FDG) concentrations leading to comparable positron emission tomography (PET)
activity concentrations. Middle panel: Schematic representation of total FDG-PET activity as a function of arterial wall volume. Model-based
PET analysis allows dissection of the PET signal and identification of the relative contribution of sub-resolution tissues. Macrophages ac-
count overall for a minor proportion of the arterial wall total activity. Bottom panel: Examples of arterial wall sections with different
volumes. Red stains show muramidase-positive areas (macrophages).
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE. In a pig model,
FDG accumulation is not specific for plaque macrophages, but it
occurs in other arterial wall cells as well.
TRANSLATIONAL OUTLOOK: Analysis of PET/CT signals
holds promise as a quantitative technique to measure various
components of atherosclerotic tissue.
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1231of hypotheses raised by human cell culture studies,
including the comparable glucose uptake of SMCs
with macrophages, and the increased glucose uptake
in hypoxic macrophages (11).
It is also important to note that our conclusions are
not in conflict with any human studies, because there
have been no comparable studies of the physical
localization of in vivo delivered FDG in human pla-
ques and arterial media at the typical time point for
scans. Human carotid endarterectomy specimens
have been incubated with radio-labeled deoxyglucose
ex vivo (28), but the lack of plaque perfusion/
oxygenation and the typical absence of the full arte-
rial media in endarterectomies are important
limitations.
IMPLICATIONS FOR CLINICAL FDG-PET TRIALS.
Several clinical trials have demonstrated reductions in
arterial FDG-PET signal following cholesterol-
lowering and other therapies (4,5). Our conclusions
are not at odds with these findings, but they suggest
that additional mechanisms to alterations in macro-
phage content or phenotype could be involved.
Further studies are needed of how changes in athero-
sclerotic disease activity are reflected in glucose
metabolism of not only macrophages, but also other
vascular cells.
Our findings raise particular caution against the
use of the ascending aorta as an imaging endpoint,
because the thick FDG-accumulating arterial media
can overwhelm plaque signal. Recently, an expert
group evaluating clinical FDG-PET imaging data also
reached the conclusion that the ascending aorta may
be less sensitive for detecting effects of interventions
(29). We believe that the mechanistic explanation
provided in the present study adds further weight to
this recommendation.
STUDY LIMITATIONS. Pigs do not develop note-
worthy carotid lesions, and we could therefore not
investigate the performance of FDG-PET for carotidplaques. Human plaques often have lower total cellu-
larity than the more rapidly evolving plaques in min-
ipigs, and ratios between different cell types may also
differ, which could translate into different contribu-
tions of the FDG accumulating cell types. However,
there is no evidence that human plaques (8–10) are
more dominated by macrophages than D374Y-PCSK9
minipig lesions (Figure 2) (14). Furthermore, our data
regarding the effect of hypoxia on macrophage FDG
accumulationwere generated on exploratory basis and
need confirmation in future experiments.
CONCLUSIONS
In a large animal model with human-like vessel
structure and atherosclerosis, the entire arterial wall,
including SMCs in the arterial media, accumulates
FDG. This is relevant to consider in the interpretation
of FDG-PET/CT trials and may provide mechanistic
insight into hitherto poorly understood observations
from the clinical imaging literature.
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